246 related articles for article (PubMed ID: 18083377)
1. Management of metastatic melanoma.
Tawbi HA; Kirkwood JM
Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy resistance abrogation in metastatic melanoma.
Tawbi HA; Buch SC
Clin Adv Hematol Oncol; 2010 Apr; 8(4):259-66. PubMed ID: 20505649
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
Eggermont AM; Kirkwood JM
Eur J Cancer; 2004 Aug; 40(12):1825-36. PubMed ID: 15288283
[TBL] [Abstract][Full Text] [Related]
4. Treatment for metastatic malignant melanoma: old drugs and new strategies.
Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
[TBL] [Abstract][Full Text] [Related]
5. Management of metastatic melanoma 2005.
O'Day S; Boasberg P
Surg Oncol Clin N Am; 2006 Apr; 15(2):419-37. PubMed ID: 16632224
[TBL] [Abstract][Full Text] [Related]
6. The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).
Guida M; Tommasi S; Strippoli S; Natalicchio MI; De Summa S; Pinto R; Cramarossa A; Albano A; Pisconti S; Aieta M; Ridolfi R; Azzariti A; Guida G; Lorusso V; Colucci G
BMC Cancer; 2018 May; 18(1):552. PubMed ID: 29747595
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and targeted therapy combinations in advanced melanoma.
Flaherty KT
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2366s-2370s. PubMed ID: 16609060
[TBL] [Abstract][Full Text] [Related]
8. Individualized therapy of disseminated cancer using malignant melanoma as a model.
Hauschild A; Egberts F; Russo P; Kähler KC
Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for metastatic melanoma.
Mandarà M; Nortilli R; Sava T; Cetto GL
Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649
[TBL] [Abstract][Full Text] [Related]
10. Treatments for metastatic melanoma: synthesis of evidence from randomized trials.
Lui P; Cashin R; Machado M; Hemels M; Corey-Lisle PK; Einarson TR
Cancer Treat Rev; 2007 Dec; 33(8):665-80. PubMed ID: 17919823
[TBL] [Abstract][Full Text] [Related]
11. New drugs in melanoma: it's a whole new world.
Eggermont AM; Robert C
Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
[TBL] [Abstract][Full Text] [Related]
12. Systemic chemotherapy.
Klimek VM; Wolchok JD; Chapman PB; Houghton AN; Hwu WJ
Clin Plast Surg; 2000 Jul; 27(3):451-61, ix-x. PubMed ID: 10941565
[TBL] [Abstract][Full Text] [Related]
13. Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results.
Egberts F; Kahler KC; Livingstone E; Hauschild A
Onkologie; 2008 Jul; 31(7):398-403. PubMed ID: 18596389
[TBL] [Abstract][Full Text] [Related]
14. Oblimersen in the treatment of metastatic melanoma.
Tarhini AA; Kirkwood JM
Future Oncol; 2007 Jun; 3(3):263-71. PubMed ID: 17547520
[TBL] [Abstract][Full Text] [Related]
15. [In vitro drug sensitivity profiling in melanoma].
Ugurel S
J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
[No Abstract] [Full Text] [Related]
16. Impact of regional chemotherapy for melanoma metastases.
Voigt H
Anticancer Res; 1988; 8(3):347-9. PubMed ID: 2455471
[TBL] [Abstract][Full Text] [Related]
17. [Current chemo- and hormone therapy in disseminated malignant melanoma of the skin].
Akimov MA; Gershanovich ML
Vopr Onkol; 1999; 45(4):341-9. PubMed ID: 10532089
[No Abstract] [Full Text] [Related]
18. Prospects for non-immunological molecular therapeutics in melanoma.
Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutics, chemoresistance and the management of melanoma.
Rass K; Hassel JC
G Ital Dermatol Venereol; 2009 Feb; 144(1):61-78. PubMed ID: 19218912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]